Literature DB >> 1827730

Expression of type 1 blood group precursor in human gastric carcinoma.

E Blasco1, A Gutierrez-Hoyos, M Lojendio, A Cosme, J I Arenas.   

Abstract

The surface epithelium of normal gastric mucosa from patients with gastric adenocarcinoma expressed the type 1 blood group precursor only in Lewis (Le) non-secretor individuals, Le a+b- (se/se, Le/-) and Le a-b- (se/se, le/le). In secretors, the superficial mucosa was negative. Deep areas of the mucosa showed no type 1 precursor regardless of secretor status. Expression of type 1 precursor was anomalously found in neoplastic cells in 14 of 16 Le a-b+ (secretors) patients and in 4 of 5 Le a-b- (secretors) patients. The 1 Le a-b- non-secretor carcinoma expressed type 1 precursor strongly. 6 of 8 Le a+b- non-secretor carcinomas showed positivity for the monoclonal antibody K-21. Thus the type 1 precursor reacted with the non-neoplastic gastric surface of non-secretors but not with those of secretors, and also with most gastric adenocarcinoma regardless of secretor status and Lewis phenotype.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1827730     DOI: 10.1016/0277-5379(91)90396-u

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  3 in total

1.  The aberrant expression of Lewis a antigen in intestinal metaplastic cells of gastric mucosa is caused by augmentation of Lewis enzyme expression.

Authors:  Y Ikehara; S Nishihara; T Kudo; T Hiraga; K Morozumi; T Hattori; H Narimatsu
Journal:  Glycoconj J       Date:  1998-08       Impact factor: 2.916

Review 2.  Cancer vaccines and carbohydrate epitopes.

Authors:  Jamie Heimburg-Molinaro; Michelle Lum; Geraldine Vijay; Miten Jain; Adel Almogren; Kate Rittenhouse-Olson
Journal:  Vaccine       Date:  2011-10-01       Impact factor: 3.641

3.  Expression of blood group-related antigens in neoplastic uterine cervix.

Authors:  Cecilia Guzmán-Bistoni; Bene Pinillos; M Carmen Blanco-Arias; Asmiria Arenas de Sotolongo; Julia Molina; Jorge García-Tamayo; Eduardo Blasco-Olaetxea
Journal:  Clin Transl Oncol       Date:  2008-04       Impact factor: 3.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.